Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration

BACKGROUND: The main objective of this study was to develop novel BSA nanoparticles (BSA NPs) for improving the bioavailability of curcumin as an anticancer drug, and those BSA NPs were galactosylated for forming the curcumin-loaded galactosylated BSA nanoparticles (Gal-BSA-Cur NPs), thus enhancing...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yike, Hu, Lu, Huang, Shan, Xu, Wanjun, Wan, Jingyuan, Wang, Dandan, Zheng, Guocan, Xia, Zhining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289229/
https://www.ncbi.nlm.nih.gov/pubmed/30584302
http://dx.doi.org/10.2147/IJN.S184379

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289229/
https://www.ncbi.nlm.nih.gov/pubmed/30584302
http://dx.doi.org/10.2147/IJN.S184379

Ejemplares similares